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CONSENSUS STATEMENT
An ever-growing volume of peer-reviewed publications speaks to the recent and
rapid growth in both scope and understanding of exercise immunology. Indeed,
more than 95% of all peer-reviewed publications in exercise immunology (cur-
rently >2, 200 publications using search terms “exercise” and “immune”) have
been published since the formation of the International Society of Exercise and
Immunology (ISEI) in 1989 (ISI Web of KnowledgeSM). We recognise the epi-
demiological distinction between the generic term “physical activity” and the spe-
cific category of “exercise”, which implies activity for a specific purpose such as
improvement of physical condition or competition. Extreme physical activity of
any type may have implications for the immune system. However, because of its
emotive component, exercise is likely to have a larger effect, and to date the great
majority of our knowledge on this subject comes from exercise studies.
In this position statement, a panel of world-leading experts provides a consensus of
current knowledge, briefly covering the background, explaining what we think we
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know with some degree of certainty, exploring continued controversies, and point-
ing to likely directions for future research. Part one of this position statement focus-
es on ‘immune function and exercise’ and part two on ‘maintaining immune
health’. Part one provides a brief introduction and history (Roy Shephard) followed
by sections on: respiratory infections and exercise (Maree Gleeson); cellular innate
immune function and exercise (Jeffrey Woods); acquired immunity and exercise
(Nicolette Bishop); mucosal immunity and exercise (Michael Gleeson and Nico-
lette Bishop); immunological methods in exercise immunology (Monika Fleshner);
anti-inflammatory effects of physical activity (Charlotte Green and Bente Peder-
sen); exercise and cancer (Laurie Hoffman-Goetz and Connie Rogers) and finally,
“omics” in exercise (Hinnak Northoff, Asghar Abbasi and Perikles Simon).
The focus on respiratory infections in exercise has been stimulated by the com-
monly held beliefs that the frequency of upper respiratory tract infections (URTI)
is increased in elite endurance athletes after single bouts of ultra-endurance exer-
cise and during periods of intensive training. The evidence to support these con-
cepts is inconclusive, but supports the idea that exercised-induced immune sup-
pression increases susceptibility to symptoms of infection, particularly around the
time of competition, and that upper respiratory symptoms are associated with per-
formance decrements. Conclusions from the debate on whether sore throats are
actually caused by infections or are a reflection of other inflammatory stimuli
associated with exercise remains unclear.
It is widely accepted that acute and chronic exercise alter the number and function of
circulating cells of the innate immune system (e.g. neutrophils, monocytes and natu-
ral killer (NK) cells). A limited number of animal studies has helped us determine
the extent to which these changes alter susceptibility to herpes simplex and influen-
za virus infection. Unfortunately, we have only ‘scratched the surface’ regarding
whether exercise-induced changes in innate immune function alter infectious dis-
ease susceptibility or outcome and whether the purported anti-inflammatory effect
of regular exercise is mediated through exercise-induced effects on innate immune
cells. We need to know whether exercise alters migration of innate cells and whether
this alters disease susceptibility. Although studies in humans have shed light on
monocytes, these cells are relatively immature and may not reflect the effects of
exercise on fully differentiated tissue macrophages. Currently, there is very little
information on the effects of exercise on dendritic cells, which is unfortunate given
the powerful influence of these cells in the initiation of immune responses.
It is agreed that a lymphocytosis is observed during and immediately after exer-
cise, proportional to exercise intensity and duration, with numbers of cells (T
cells and to a lesser extent B cells) falling below pre-exercise levels during the
early stages of recovery, before returning to resting values normally within 24 h.
Mobilization of T and B cell subsets in this way is largely influenced by the
actions of catecholamines. Evidence indicates that acute exercise stimulates T cell
subset activation in vivo and in response to mitogen- and antigen-stimulation.
Although numerous studies report decreased mitogen- and antigen-stimulated T
cell proliferation following acute exercise, the interpretation of these findings
may be confounded by alterations in the relative proportion of cells (e.g. T, B and
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NK cells) in the circulation that can respond to stimulation. Longitudinal training
studies in previously sedentary people have failed to show marked changes in T and
B cell functions provided that blood samples were taken at least 24 h after the last
exercise bout. In contrast, T and B cell functions appear to be sensitive to increases in
training load in well-trained athletes, with decreases in circulating numbers of Type 1
T cells, reduced T cell proliferative responses and falls in stimulated B cell Ig synthe-
sis. The cause of this apparent depression in acquired immunity appears to be related
to elevated circulating stress hormones, and alterations in the pro/anti-inflammatory
cytokine balance in response to exercise. The clinical significance of these changes
in acquired immunity with acute exercise and training remains unknown.
The production of secretory immunoglobulin A (SIgA) is the major effector func-
tion of the mucosal immune system providing the ‘first line of defence’ against
pathogens. To date, the majority of exercise studies have assessed saliva SIgA as a
marker of mucosal immunity, but more recently the importance of other antimi-
crobial proteins in saliva (e.g. α-amylase, lactoferrin and lysozyme) has gained
greater recognition. Acute bouts of moderate exercise have little impact on
mucosal immunity but prolonged exercise and intensified training can evoke
decreases in saliva secretion of SIgA. Mechanisms underlying the alterations in
mucosal immunity with acute exercise are probably largely related to the activa-
tion of the sympathetic nervous system and its associated effects on salivary pro-
tein exocytosis and IgA transcytosis. Depressed secretion of SIgA into saliva dur-
ing periods of intensified training and chronic stress are likely linked to altered
activity of the hypothalamic-pituitary-adrenal axis, with inhibitory effects on IgA
synthesis and/or transcytosis. Consensus exists that reduced levels of saliva SIgA
are associated with increased risk of URTI during heavy training.
An important question for exercise immunologists remains: how does one measure
immune function in a meaningful way? One approach to assessing immune function
that extends beyond blood or salivary measures involves challenging study partici-
pants with antigenic stimuli and assessing relevant antigen-driven responses includ-
ing antigen specific cell-mediated delayed type hypersensitivity responses, or circu-
lating antibody responses. Investigators can inject novel antigens such as keyhole
limpet haemocyanin (KLH) to assess development of a primary antibody response
(albeit only once) or previously seen antigens such as influenza, where the subsequent
antibody response reflects a somewhat more variable mixture of primary, secondary
and tertiary responses. Using a novel antigen has the advantage that the investigator
can identify the effects of exercise stress on the unique cellular events required for a
primary response that using a previously seen antigen (e.g. influenza) does not per-
mit. The results of exercise studies using these approaches indicate that an acute bout
of intense exercise suppresses antibody production (e.g. anti-KLH Ig) whereas mod-
erate exercise training can restore optimal antibody responses in the face of stressors
and ageing. Because immune function is critical to host survival, the system has
evolved a large safety net and redundancy such that it is difficult to determine how
much immune function must be lost or gained to reveal changes in host disease sus-
ceptibility. There are numerous examples where exercise alters measures of immuni-
ty by 15-25%.Whether changes of this magnitude are sufficient to alter host defence,
disease susceptibility or severity remains debatable.
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Chronic inflammation is involved in the pathogenesis of insulin resistance, athero-
sclerosis, neurodegeneration, and tumour growth. Evidence suggests that the pro-
phylactic effect of exercise may, to some extent, be ascribed to the anti-inflammato-
ry effect of regular exercise mediated via a reduction in visceral fat mass and/or by
induction of an anti-inflammatory environment with each bout of exercise (e.g. via
increases in circulating anti-inflammatory cytokines including interleukin (IL)-1
receptor antagonist and IL-10). To understand the mechanism(s) of the protective,
anti-inflammatory effect of exercise fully, we need to focus on the nature of exercise
that is most efficient at allieviating the effects of chronic inflammation in disease.
The beneficial effects of endurance exercise are well known; however, the anti-
inflammatory role of strength training exercises are poorly defined. In addition, the
independent contribution of an exercise-induced reduction in visceral fat versus
other exercise-induced anti-inflammatory mechanisms needs to be understood bet-
ter. There is consensus that exercise training protects against some types of cancers.
Training also enhances aspects of anti-tumour immunity and reduces inflammatory
mediators. However, the evidence linking immunological and inflammatory mecha-
nisms, physical activity, and cancer risk reduction remains tentative.
In the very near future, genomics, proteomics, and metabolomics may help exer-
cise immunologists to better understand mechanisms related to exercise-induced
modulation of the immune system and prevention (or reduced risk) of diseases by
exercise training. In addition, these technologies might be used as a tool for opti-
mizing individual training programmes. However, more rigorous standardization
of procedures and further technological advances are required before practical
application of these technologies becomes possible.
Key Words: exercise; sport; training; immune; pathogen; infection; innate;
acquired; mucosal; saliva; leukocyte; monocyte; neutrophil; granulocyte; lympho-
cyte; immunoglobulin; method; cytokine; interleukin; inflammation; cancer;
genomics; proteomics; metabolomics
INTRODUCTIONAND HISTORY
Two recent papers have summarized the scientific history of exercise immunology
(263) and its development as a specific discipline (264) with its own international
society and a dedicated journal. Exercise immunology has quite a short history
relative to many branches of the exercise sciences, the modern era of careful epi-
demiological investigations and precise laboratory studies beginning in the mid
1980s. However, an ever-growing volume of peer-reviewed publications speaks to
a rapid growth in both scope and understanding of the topic since that date. In
addition to enquiries into many areas of intrinsic scientific interest, exercise immu-
nologists have found diverse applications for their talents in augmenting popula-
tion health and maintaining high performance athletes in peak physical condition.
From early during the 20th century, clinicians had pointed to what seemed adverse
effects of prolonged heavy exercise upon both resistance to and the course of var-
ious viral and bacterial diseases (25, 261). These concerns were seemingly sub-
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stantiated by a 2-6 fold increase in the reported symptoms of upper respiratory
infection (URTI) for several weeks following participation in marathon or ultra-
marathon events (200, 224). The influence of exercise on the risks of URTI is dis-
cussed in the following section. A transient fall in the circulating natural killer
(NK) cell count following a sustained bout of vigorous exercise (270) seemed to
offer a mechanism explaining the increase in risk; the temporary lack of NK cells
and killer cell activity offered an “open window,” a period when a reduced resistance
to viral infections allowed easier access to infecting micro-organisms. Innate immu-
nity is discussed in detail later in this part of the position statement. In one report,
the reduction in NK cell count persisted for seven days following exercise (259), but
in most studies, circulating NK cell numbers and activity have been described as
being depressed for only a few hours, raising doubts as to whether the “window”
was open long enough to account for the increased vulnerability to infection. More-
over, technical advances (particularly in automated cell counting and identification)
(85) have underlined that exercise does not destroy NK cells; rather, they are tem-
porarily relocated to reservoir sites such as the walls of peripheral veins in response
to the exercise-induced secretion of catecholamines and activation of adhesion mol-
ecules (266). A more plausible explanation for the reported increase in URTI during
heavy training and following participation in long-distance events appeared as atten-
tion shifted to immunoglobulins in general, and in particular to a depression of
front-line defences through a decrease in the mucosal secretory functions of the nose
and salivary glands (152, 298). The influence of exercise on mucosal immunity is
discussed in more detail later in this part of the position statement.
The hypothesis of a U-shaped relationship between physical activity and resist-
ance to disease, although based on a relatively limited amount of laboratory and
epidemiological data (202, 267), has made intuitive sense, jibing with the more
general belief that although regular moderate doses of physical activity have ben-
eficial effects on health, excessive amounts or intensities of physical activity have
negative consequences. In the case of the immune system, one suggestion has
been that an excess of physical activity provokes something analogous to clinical
sepsis, with tissue destruction from an excessive inflammatory reaction (260).
Although initially conceived simply in the context of URTI (201), the concept of
a U-shaped response has now been extended to cover the effects of physical activ-
ity upon a variety of clinical disturbances of immune function. In terms of cancer
prevention and therapy (268), regular moderate physical activity has been shown
to reduce the risk of developing certain forms of the disease (265); it also limits
the risk of metastasis, at least in experimental animals (156). Exercise and cancer
is discussed in more detail in this part of the position statement. On the other
hand, excessive exercise has been shown to cause DNA damage and apoptosis
(176, 186). Ageing is increasingly considered in part as an expression of disturbed
immune function; high concentrations of pro-inflammatory cytokines are seen in
the elderly, and seemingly contribute to such problems of ageing as sarcopenia,
neural degeneration and Alzheimer’s Disease. Moreover, appropriate amounts of
physical activity can control levels of pro-inflammatory cytokines, and appear to
have a beneficial effect on these manifestations of ageing (188). Certain auto-
immune conditions also respond to carefully regulated physical activity pro-
grammes, although it has yet to be established clearly whether benefit occurs
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through some direct modulation of cell counts and cytokines, or through changes
in the activity of transcription factors for pro-inflammatory cytokines (9).
Developments in fluorescent antibodies have allowed exercise immunologists to
identify an ever-growing number of cell sub-types and receptors. At the same
time, new cytokine identification kits and methods in molecular technology (173)
have allowed the examination of humoral factors that are present in the body for
very short periods and in extremely low concentrations; an increasingly complex
range of pro- and anti-inflammatory cytokines has been revealed. The exercise
immunologist seems drawn into the main streams of sports medicine, physiology
and even psychology. A fascinating cascade of cytokines is now thought to have
an important role not only in controlling exercise-induced inflammation, but also
in regulating the release and necessary flow of metabolites (221). Development of
the sub-discipline of psycho-neuroimmunology (141) has emphasized that vigor-
ous exercise should be considered as but one example of the body’s reaction to a
variety of stressors (221), with an important two-way communication between
peripheral immunocytes and hypophyseal centres, involving a wide variety of
hormones and autonomic pathways (157). A section in the second part of the
position statement deals with stress and immune function.
On the sports field, exercise immunologists are increasingly asked to develop pro-
cedures to detect such abuses as blood doping (185) and gene transfer (11) (see
“Omics” section in this part of the position statement). However, attempts to pin-
point immunological markers of over-training have as yet proved inferior to tradi-
tional indices such as mood state and physical performance (as discussed in the
second part of this position statement). A variety of nutritional supplements to
date seem to have had only limited success in blunting the immune impairment
associated with heavy exercise (as discussed in the second part of this position
statement).
These are a few of the important topics on which a panel of world experts provide
a succinct consensus of current knowledge, briefly covering the relevant back-
ground, exploring continued controversies, and pointing to likely directions of
future research.
RESPIRATORY INFECTIONSAND EXERCISE
Background
There are more uncertainties than evidence based facts on the nature of upper respi-
ratory tract infections (URTI) associated with exercise, particularly in high per-
formance athletes. Although URTI or ‘sore throats’ are the most common reason for
presentation of elite athletes to a sports medicine clinic (62, 77, 80), the debate on
whether sore throats are actually caused by infections, or are a reflection of other
inflammatory stimuli associated with exercise remains unclear (48, 106, 242).
The costs associated with identification of the underlying causes of upper respira-
tory symptoms (URS) and the delay in obtaining results of investigative tests
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means that infections are not usually verified by pathology examinations. Physi-
cian confirmation of an infective cause of the symptoms, based on clinical signs
and symptoms, has until recently been considered the ‘gold standard’ for exercise
studies, but the involvement of physicians in assessments and diagnosis is not
common in research settings. Recently, the ‘gold standard’ of physician verified
diagnosis of URTI has also come under scrutiny, and been found less than ideal
(48). Very few studies have examined the underlying causes of URS and extensive
clinical investigations of athletes are rare (48, 242).
The focus on respiratory infections in exercise has been stimulated by the com-
monly held beliefs that the frequency of URTI is increased in elite endurance ath-
letes and that their incidence is associated with more intensive training (201). The
evidence to support these concepts is inconclusive, but does, support the idea that
exercised-induced immune suppression increases susceptibility to symptoms of
infection and that URS are associated with performance decrements.
Evidence based consensus and uncertainties
Over the past thirty years, there have been numerous investigations examining the
association between changes in immune parameters and the risk of URTI in ath-
letic and non-exercising populations. The only immune measures to date to show
consistent relationships with URS in exercising populations have been changes in
salivary IgA concentrations and secretion rates (19, 89, 263). A section focusing
on exercise and mucosal immunity appears later in this part of the position state-
ment.
Altered mucosal immunity and risk of symptoms of URTI
The inverse relationship between salivary IgA concentrations and risk of URTI in
exercising and non-exercising populations has demonstrated differences between
these two populations (76, 89, 98, 232). The different population risk profiles are
predominantly due to differences in the levels of intensity and quantum of exercise
undertaken by very fit elite athletes and non-elite exercising or sedentary popula-
tions. The impact of exercise intensity on salivary IgA concentrations and secretion
rates has demonstrated greater decreases in salivary IgA associated with prolonged
high intensity exercise, whereas moderate increases in salivary IgA occur in response
to short duration moderate intensity exercise (6, 19, 23, 98, 129, 148, 163, 232).
Although study populations vary, the association of an increased risk of URS
and/or URTI with lower concentrations of salivary IgA and secretion rates has
been consistent for high-performance endurance athletes undertaking intensive
training (64, 91, 92, 95, 97, 148, 187, 195-198, 201, 320). Similarly, the increases
in salivary IgA observed after moderate exercise training may contribute to the
reduced susceptibility to URTI associated with regular moderate exercise (3, 129).
Symptoms and frequency
Although there are many anecdotal reports that URTIs are more common in elite
athletes, there is very little reported evidence to support this commonly held belief.
This uncertainty is compounded by the current uncertainty around whether the URS
are due to infections or other inflammatory stimuli mimicking URTI (48, 242).
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Retrospective and prospective longitudinal studies have identified that the majori-
ty of elite athletes experience symptoms of URTI at a rate similar to the general
population (48, 78, 234). However, the episodes of URS in elite athletes do not
follow the usual seasonal patterns of URTI observed in the general population, but
rather occur during or around competitions (97, 160, 198, 224). Symptoms occur
more frequently during the high intensity training and taper period prior to com-
petitions in some sports, such as swimming (79, 89, 91), but in other endurance
sports, such as long distance running, URS appear more frequently after a compe-
tition (49, 198, 224). Illness-prone athletes may also be susceptible to URS during
regular training periods or following increases in training load (80). The com-
monly reported short-term duration of URS (1-3 days) in most studies suggests
that in most instances a primary infection is unlikely and the symptoms may be
due to viral reactivation (97, 242) or other causes of exercise-induced inflamma-
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Pathogen identified by Triathletes (n=63) Elite athletes (n=70) Elite athletes (n=41)
microbial and viral investigation undertaking routine presenting to a sports with persistent fatigue
training and clinic and poor performance
competitions
Spence et al. (282) Cox et al. (48) Reid et al. (242)
Rhinovirus 7 6 -
Influenzae (A & B) 7 1 -
Parainfluenzae (1, 2 & 3) 4 3 -
Adenovirus 0 2 -
Coronavirus 2 0 -
Metapneumovirus 1 0 -
Epstein Barr virus
(primary infection) 1 1 3
EBV reactivation - 1 8
Cytomegalovirus 0 0 5
Herpes simplex virus (types 1 & 2) 0 - -
Ross River virus - - 1
Toxoplasmosis - - 1
Mycoplasma pneumoniae 0 1 1
Streptococcus pneumonia 2 1 -
Staphylococcus pyogenes 0 1 -
Haemophilus influenzae 0 0 -
Moraxella catarrhalis 0 0 -
Enterococcus spp 0 0 -
Table 1. Pathogens identified and the number of cases in comprehensive prospective stud-
ies of athletes presenting with symptoms of upper respiratory infections in 1) a cohort of
high performance triathletes during training and competitions (282); 2) a study of elite ath-
letes from a variety of sports undertaking routine training presenting to a sports clinic with
URS (48); and 3) a cohort of elite athletes experiencing recurrent episodes of URS associat-
ed with fatigue and performance decrements (242). Where investigations were not per-
formed this is recorded as (-).
tion. The evidence that URS are associated with poor performance is also limited.
In the month prior to an international competition URS have been associated with
decrements in performance in elite swimmers (235), suggesting that regardless of
whether the URS are due to infections or other inflammatory stimuli, they can
impact on performance at an elite level. However, a small proportion of high-per-
formance endurance athletes experience recurrent episodes of URS at significant-
ly higher rates than the incidence in the general population (92, 234), and in these
athletes the URS are associated with significant persisting fatigue and poor per-
formance (79, 91, 93, 242).
Infections versus inflammation
The few studies that have undertaken pathology testing to identify infectious from
non-infectious causes of the episodes of URS in high-performance athletes have
revealed that bacterial infections account for about 5% of the episodes (48, 94,
242, 282). Most episodes of URS with an identified infectious cause are of viral
origin, but these account for only about 30-40% of the episodes in each study (48,
282). The bacterial and viral pathogens identified in these comprehensive studies
indicate that the infections are caused by the usual respiratory pathogens associat-
ed with URTI (246) in the general population (Table 1).
However, the profile of infections in a study of elite athletes experiencing recur-
rent URS associated with long-term fatigue and poor performance identified a
high percentage as having herpes group viruses (e.g. cytomegalovirus) or evi-
dence of Epstein Barr Virus (EBV) reactivation (242) (Table 1). Epstein Barr viral
reactivation has also been demonstrated in association with URS in some
endurance sports (97, 242), which may account for the short duration of the
symptoms reported in most studies, resulting from viral reactivation rather than
primary infection. However, in a study examining the prophylactic use of an
antiviral treatment in elite runners, it was shown that not all episodes of URS
were associated with EBV expression (50) and that the frequency of EBV expres-
sion differed between sports (50, 97). Although an anti-herpes virus treatment was
effective in reducing EBV expression in elite long-distance runners, it was not
effective in reducing the frequency of episodes of URS, once again suggesting
other non-infective causes for the URS in elite athletes (50).
Physician diagnosis of infections as the cause of the URS has recently come
under scrutiny (48) and in conjunction with a previous study by Reid et al. (242)
has identified that elite athletes suffering recurrent episodes of URS need more
exhaustive clinical assessments to exclude non-infectious yet treatable causes of
the symptoms, such as asthma, allergy, autoimmune disorders, vocal cord dys-
function and unresolved non-respiratory infections. In these studies, other dis-
eases with an inflammatory basis accounted for 30-40% of episodes of URS in
elite athletes. These studies identified that URS were divided into approximately
one-third proportions as having an infectious cause, non- infectious medical
cause and an unknown aetiology. The speculative causes of the ‘unknown-aetiol-
ogy’ group could include physical or mechanical damage such as drying of the
airways (16); asthma and allergic airway inflammation (106); psychological
impacts of exercise on membrane integrity and immunity (22); and the migration
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to the airways of inflammatory cytokines generated during damage to muscles
susained in eccentric exercise (214, 222). Multiple stressors experienced by ath-
letes, biological, physical and psychological, are likely to induce neurological
and endocrine responses in addition to alterations in immune parameters; these
share common exercise-induced pathways (207) that may result in URS. Howev-
er, there is currently little direct evidence to support any of these mechanisms
being associated with URS, respiratory infections or susceptibility to infections
in athletes.
Cytokine regulation
Cytokine responses to exercise (particularly those associated with micro-trauma
and or glycogen depletion of muscle tissue (27, 214, 222, 294)) are reasonably
well characterised (as discussed in the section on anti-inflammatory effects of
physical activity later in this part of the position statement). They are likely to
play an important role in modulating post-exercise changes in immune function
that increase the risk of infection or the appearance of inflammatory symptoms
(294). The pro-inflammatory responses to exercise have the potential to be
involved in expression of URS that mimic URTI. A study comparing cytokine
responses to exercise in illness-prone distance runners demonstrated impaired
anti-inflammatory cytokine regulation compared to runners who did not suffer
frequent episodes of URS (51). A recent cytokine gene polymorphism study by
Cox et al. (47) identified an underlying genetic predisposition to high expression
of the pro-inflammatory interleukin-6 in athletes prone to frequent URS. These
studies add further weight to the evidence that suggests infections are not the only
cause of the symptoms of ‘sore throat’. They are supported by studies examining
the prophylactic use of topical anti-inflammatory sprays to prevent URS in long-
distance runners which demonstrate a reduction in the severity of the symptoms
but not the frequency of episodes following marathon races (49, 257).
Conclusions and future directions
Interpreting the findings of studies on the role of respiratory infections in exercise
is often limited by the lack of pathogen identification. Regardless of the underly-
ing stimulus for the inflammatory symptoms the implications of the upper airway
symptoms for athletes may be the same. However, unless the symptoms are con-
firmed as infections, reference to symptoms as URS rather than as infections or
URTI should become the accepted reporting standard, particularly when there is
no physician assessment.
The current consensus is that the cause of URS in athletic populations is uncer-
tain. Physician identification can no longer be considered the gold standard and
symptoms should only be referred to as infection if a pathogen has been identi-
fied. Although diagnostic pathology is rarely performed, in the few studies that
have examined pathology, the infections identified in most athletes have been the
common respiratory pathogens observed in the general population.
Inflammation from non-infective causes is common among athletes and many
will have underlying treatable conditions. As differentiation between the inflam-
matory causes of URS is currently not feasible in most research settings, appro-
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priate treatments are difficult to prescribe universally. Athletes with recurrent
URS associated with long-term fatigue and poor performance do, however, war-
rant more exhaustive clinical investigations, including assessment for possible
involvement of the herpes group viruses. Identifying athletes with an underlying
genetic predisposition to pro-inflammatory responses to exercise may be useful in
managing the training regimens of elite athletes, particularly those who suffer
recurrent episodes of URS associated with fatigue and poor performance.
The two main questions to be resolved about the relationship between respiratory
infections and exercise are: 1) whether the upper respiratory tract symptoms are
actually infections and if so whether they can be prevented or treated; and 2) if the
symptoms are not due to infections can the different causes of the inflammation
be segregated in the complex paradigm of elite training to optimise the illness-
prone athlete’s training and performance.
CELLULAR INNATE IMMUNE FUNCTIONAND EXERCISE
Background
Innate immunity is our first line of defence against infectious pathogens and is
intimately involved in tissue damage, repair and remodeling. The major differ-
ence between innate immune responses and adaptive responses is that innate
responses do not strengthen upon repeated exposure (there is no memory func-
tion). In addition, innate responses are less specific in terms of pathogen recogni-
tion. So, whereas innate responses recognize classes of pathogens (e.g. gram-neg-
ative bacteria) through toll-like receptors (TLRs), lymphocytes exhibit exquisite
specificity for epitopes of individual pathogens (e.g. influenza virus). The innate
branch of the immune system includes both soluble factors and cells. Soluble fac-
tors include complement proteins which mediate phagocytosis, control inflamma-
tion and interact with antibodies, interferon α/β which limits viral infection, and
anti-microbial peptides like defensins which limit bacterial growth. Major cells of
the innate immune system include neutrophils which are first line defenders
against bacterial infection, dendritic cells (DCs) which serve to orchestrate
immune responses, macrophages (Mφ’s) that perform important phagocytic, regu-
latory and antigen presentation functions, and natural killer (NK) cells which rec-
ognize altered host cells (e.g. virally infected or transformed). However, many
host cells, not just those classified as innate immune cells, can initiate responses
to pathogenic infection. Although partitioning the immune system into innate and
adaptive systems makes the system easier to understand, in fact, these branches
are inextricably linked with each other. For example, the innate immune system
helps to develop specific immune responses through antigen presentation, where-
as cells of the adaptive system secrete cytokines that regulate innate immune cell
function. This section will focus on the influence of acute and chronic exercise on
cellular components of innate immunity (Figure 1). A later section in this part of
the position statement will focus on exercise and inflammatory cytokines which
constitute the products of innate immune and other cells.
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Consensus
Acute exercise and cellular innate immune function
Neutrophils
Acute exercise results in a first, rapid and profound neutrophilia (increase in
blood neutrophil number) followed by a second, delayed increase in blood neu-
trophil count a few hours later, the magnitude of which is related to both the
intensity and duration of exercise (216, 247). The initial increase is likely due to
demargination caused by shear stress and catecholamines, whereas the later
increase may be due to cortisol-induced release of neutrophils from the bone mar-
row (162). Unstimulated neutrophil degranulation, phagocytosis and oxidative
burst activity are increased by an acute bout of exercise but there is a reduced
degranulation and oxidative burst in response to bacterial stimulation that can last
for many hours (215, 216, 247). This indicates that although exercise may mobi-
lize highly functional neutrophils into the circulation, in recovery, their ability to
respond to exogenous stimuli may be diminished. Marginated neutrophils are
more mature than recently released neutrophils and this likely has implications
for the study of exercise on neutrophil function, although this does not appear to
influence respiratory burst activity (276).
Monocytes/Macrophages
Many studies have examined the influence of acute exercise on human CD14+
blood monocytes (Mo’s) which are relatively immature cells destined to become
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Figure 1. Potential mechanisms whereby acute/chronic exercise affects innate immunity.
Exercise-induced factors such as oxidative stress, increased metabolic rate, heat shock
proteins, catecholamines, cortisol and insulin-like growth factor can influence: pathogen
recognition by altering expression of recognition molecules such as toll-like or scavenger
receptors; cell trafficking by altering haematopoieisis, cell death and adhesion molecule
expression; and effector functions like oxidative burst, cytokine expression and antigen pro-
cessing and presentation. This list of potential mechanisms is not all-inclusive and very few
have been definitively tested.
tissue Mφ’s. Acute exercise results in a transient (~2 h) monocytosis and most likely
represents a shifting of Mo’s from the marginated to the circulating pool (206). This
could occur as a result of haemodynamic and/or cortisol or catecholamine-induced
release from the vascular endothelium (136). Indeed, administration of the beta-
blocker propranolol can reduce exercise-induced monocytosis (2) and adrenaline
(epinephrine) administration causes monocytosis (307). There are also reports that
exercise can affect Mo phenotype, cell surface protein, and cytokine expression. For
example, in response to acute exercise, there is a preferential mobilization of
CD14+/CD16+ expressing Mo’s (115, 289) that exhibit a pro-inflammatory pheno-
type relative to CD14+/CD16– classical Mo’s. It may be that these marginated cells
have a more mature inflammatory function for entry into tissues and are knocked off
the endothelium in response to exercise. Interestingly, the percentage of these
CD14+/CD16+ cells is reduced in recovery, perhaps indicating remarginalization or
tissue recruitment (272). Acute exercise also reduces expression of TLRs 1, 2 and 4
on CD14+ Mo’s (140). However, the extent to which these changes reflect a true
decrease versus Mo population shifts is unclear. In an attempt to reconcile this,
Simpson et al. (272) examined cell surface proteins on Mo subpopulations in
response to acute exercise. They found that TLR4 and HLA.DR (major histocompat-
ibility molecule II important in antigen presentation) expression were altered on
total CD14+ Mo’s but also on individual Mo populations, indicating that changes in
cell surface expression are not influenced solely by exercise-induced changes in Mo
subpopulations in blood. Several studies have examined Mo cytokine production
after acute exercise, finding that, although spontaneous cytokine levels in CD14+
cells change little (245, 285), acute exercise reduces TLR ligand-stimulated inter-
leukin (IL)-6, IL1-α, and tumour necrosis factor-alpha (TNF-α production (140,
286), perhaps as a consequence of reduced TLR expression. Further studies regard-
ing the effects of acute exercise on Mo TLR signaling may clarify these observations.
Because Mo’s are relatively immature, exercise-induced changes in their function
may not reflect actual tissue Mφ function which is central to inflammation and
immune responses. For this reason, animal studies have examined the influence of
exercise on tissue Mφ number and function. Both moderate and intense acute
exercise have potent stimulatory effects on phagocytosis (210), anti-tumour activ-
ity (52, 327, 328), reactive oxygen and nitrogen metabolism (327, 328), and
chemotaxis (206, 209). However, not all functions are enhanced by exercise. We
have documented prolonged exercise-induced reductions in Mφ MHC II expres-
sion (325) and antigen presentation capacity (35, 36). Some effects may be dose-
dependent as exhaustive exercise was shown to decrease alveolar Mφ anti-viral
function; this effect was correlated with increased susceptibility to Herpes sim-
plex virus (HSV)-1 infection (133, 134) and related to increased release of adre-
nal catecholamines, but not corticosterone (133). Thus, it appears that exercise,
perhaps dependent on dose with respect to some functions, can affect tissue Mφ’s
and, in some studies, disease outcomes in animals. Whether these same effects
can be generalized to humans is unknown.
Dendritic cells
The effect of acute exercise on DCs has received little attention despite the impor-
tant emergent role of these cells in the initiation of immune responses. There are
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only two studies reporting that exercise can increase circulating numbers of DCs
(59, 109) and, to our knowledge, nothing is known about acute effects of exercise
on DC function.
Natural killer (NK) cells
There is a vast literature on the acute effects of exercise on circulating NK
(CD3–CD16+CD56+) cells, perhaps because of their ease of study and large mag-
nitude change in response to exercise. Like other blood leukocytes, NK cells are
rapidly mobilized into the circulation in response to acute exercise, most likely by
increased shear stress and catecholamine-induced down-regulation of adhesion
molecule expression (15, 122, 301). There appears to be a differential mobiliza-
tion such that CD56bright NK cells are less responsive than CD56dim. Perhaps this
indicates a reduced ability to defend against pathogens during acute exercise, as
CD56bright cells are more cytotoxic. However, the health significance of exercise-
induced changes in circulating NK cells, like other leukocytes, remains unknown.
After prolonged exercise, the numbers of circulating NK cells are reduced in
blood (87), perhaps as a consequence of remarginalization or tissue migration, but
there is a relative increase in the CD56bright subset (302).
NK cell cytotoxicity (NKCC) is a major functional measure of NK activity. Early
studies demonstrated that unstimulated NKCC was dependent upon the intensity
and duration of the exercise bout (87). Immediately after a single bout of moder-
ate or exhaustive exercise there is a 50-100% increase in human peripheral blood
NKCC (87, 329). The exercise-induced increase in NKCC is largely due to an
increase in the absolute number and percentage of blood NK cells (87). NKCC
expressed on a per cell basis does not appear to change much after acute exercise
unless the bout is intense and prolonged, in which case NKCC can be depressed
for several hours, possibly indicating an enhanced period of susceptibility to
infection (90). Only a few studies have examined whether NK cells mobilized
into the circulation in response to exercise have altered sensitivity to stimulating
agents like interferon-α or IL-2 (68, 329); however, like unstimulated NKCC,
these effects are likely mediated by distributional shifts in NK cell subsets and
should not necessarily be interpreted as altered NK cell function on a per cell
basis.
Exercise training and cellular innate immune function
Neutrophils
Regular exercise training does not appear to alter blood leukocyte counts, includ-
ing neutrophils appreciably (90). However, there are a few reports that exercise
training reduces blood neutrophil counts in those with chronic inflammatory con-
ditions or neutrophils in sites of chronic inflammation (171) raising the possibili-
ty that such exercise acts in an anti-inflammatory fashion in those with inflamma-
tion. This effect could be beneficial or deleterious, dependent upon the context.
Although there is little known about the influence of exercise training on neu-
trophil function, regular exercise, especially heavy, intense training, may attenu-
ate neutrophil respiratory burst (103, 233). This could reflect a sustained effect of
previous acute exercise, as attenuation of respiratory burst has been documented
to last several days post-exercise (295).
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Monocytes/Macrophages
Both longitudinal exercise training and cross-sectional studies have shown that
physically active people exhibit reduced blood Mo inflammatory responses to
lipopolysaccharide, lower TLR4 expression, and a lower percentage of
CD14+/CD16+ ‘inflammatory’ Mo’s (73, 165, 166, 273, 290, 300). The extent to
which these effects on the relatively small blood Mo pool contribute to the anti-
inflammatory effect of exercise training is unknown. In contrast, animal studies
have demonstrated that exercise training can increase induced inflammatory
responses of peritoneal Mφ’s (128, 151, 292), indicating a possible difference
between the effects of training on blood Mo’s when compared with differentiated
tissue Mφ’s. Animal studies have the potential to shed additional light on the
source of the anti-inflammatory effect of regular exercise, especially in popula-
tions that exhibit inflammation. Indeed, in two recent studies, we have shown that
exercise training, with or without a low fat diet, reduces visceral adipose tissue
(e.g. Mφ infiltration and pro-inflammatory cytokine gene expression) and sys-
temic inflammation in high fat diet-fed mice (309, 310). Regular exercise may
also reduce Mφ infiltration into other sites of chronic inflammation, including
growing tumours (336), and this could be interpreted as a benefit given the
tumour supporting role of these cells. In contrast, reduced infiltration of Mφ’s into
sites of chronic infection could lead to morbidity, although this has not been
demonstrated. In fact, Mφ’s appear to play a definitive role in mediating the bene-
ficial effects of regular moderate exercise as it relates to intranasal infection with
HSV-1 in mice (181).
Dendritic cells
There are two reports from the same group demonstrating an effect of exercise
training on rat dendritic cells. Liao et al. (147) reported that dendritic cell number
increased after training, with no difference in costimulatory molecule (CD80 or
CD86) expression, while Chiang et al. (40) found that MHC II expression, mixed
leukocyte reaction and IL-12 production were increased in DCs from exercise
trained rats. Clearly, given the importance of DCs in early immune regulation, this
is an area ripe for investigation.
Natural killer (NK) cells
Despite much research regarding the effects of exercise training on NK cell num-
ber and function, there appears to be much controversy regarding its effect. Early
cross-sectional or intervention studies with limited subject numbers reported
modest increases in NKCC after moderate exercise training in previously seden-
tary subjects (167, 194, 202, 223, 269, 326). In larger trials, one study (65) found
that 15 weeks of moderate exercise training increased NKCC compared with
sedentary controls, while another 12-month trial found no change in NKCC in
115 post-menopausal women (31). However, intense training has been shown to
alter NK cell subsets and reduce NKCC (93, 293). Studies in animals have
demonstrated that regular exercise can increase in vivo cytotoxicity (119, 120,
155); however, the specific contribution of NK cells in mediating this exercise
effect is unclear (119).
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Controversies
Based upon the body of literature, it appears that both acute and chronic exercise
have the potential to alter both the number and function of cells of the innate
immune system (Figure 1). A limited number of animal studies have helped us
determine the extent to which these changes alter susceptibility to herpes simplex
(181) and influenza virus (149, 150, 271) infection. Unfortunately, we have only
‘scratched the surface’ regarding whether exercise-induced changes in immune
function alter infectious disease susceptibility or outcome. In addition, although
some progress has been made, we know relatively little about how acute and
chronic exercise affect innate immune cell trafficking. We need to determine
whether exercise alters migration of these cells and whether this alters disease
susceptibility. Given the important role of innate immune cells in inflammatory
states and the relationship between inflammation and chronic disease, we need to
clarify whether the purported anti-inflammatory effect of regular exercise is
mediated through exercise-induced effects on innate immune cells. In this regard,
it is of interest to know whether exercise affects Mφ phenotype (e.g. classical ver-
sus alternative). Although studies in humans shed light on Mo’s, these cells are
relatively immature and may not reflect the effects of exercise on fully differenti-
ated tissue Mφ’s. Lastly, there is very little information on the effects of exercise
on DCs, which is unfortunate given the powerful influence of these cells early in
immune responses.
ACQUIRED IMMUNITYAND EXERCISE
Background
Acquired immunity (also known as adaptive or specific immunity) is designed to
combat infections by preventing colonisation of pathogens and destroying invad-
ing micro-organisms. With only a few exceptions, it is initiated by the presenta-
tion of antigen to T helper (CD4+) lymphocytes within the peptide binding groove
of major histocompatibility complex class II molecules on antigen presenting
cells CD4+ T cells form a key part of the cell-mediated immune response, since
they orchestrate and direct the subsequent response. Helper T cell clones can be
divided into two main phenotypes, type 1 (Th1) and type 2 (Th2) cells, according
to the cytokines that they produce and release. Th1 cells play an important role in
defence against intracellular pathogens, e.g. viruses, the release of the cytokines
interferon-γ (IFN- γ) and interleukin-2 (IL-2) stimulating T cell activation and
proliferation of clones of effector cells. Memory T cells are also generated,
allowing a rapid secondary response upon subsequent exposure to the same anti-
gen. Th2 cells release IL-4, IL-5, IL-6 and IL-13 and appear to be involved in pro-
tection against extracellular parasites and stimulation of humoral immunity (pro-
duction of antibody and other soluble factors that circulate in the blood and other
body fluids). Therefore, cytokines released from Th2 cells can activate B lympho-
cytes, leading to proliferation and differentiation into memory cells and plasma
cells (although some antigens can activate B cells independently of CD4+ cells).
Plasma cells are capable of secreting vast amounts of immunoglobulin (Ig) or
antibody specific to the antigen that initiated the response. The binding of Ig to
its target antigen forms an antibody-antigen complex and both free Igs and anti-
Immune function and exercise • 21
EIR 17 2011 - position statement part 1
body-complexes circulate in the body fluids. CD8+ cells can also be classified
into type 1 (Tc1) and type 2 (Tc2) cells according to their cytokine profiles, as
described above, but the functional significance of these cells is at yet unclear. A
further set of T-cells, the naturally-occurring regulatory T-cells (Tregs) express
the phenotype CD4+CD25+ and can suppress the functional activity of lympho-
cytes by mechanisms that most likely involve secretion of cytokines including IL-
10 and TGF-β1.
Consensus: acute exercise and acquired immune function
T and B cell number
Acute exercise elicits characteristic transient biphasic changes in the numbers of
circulating lymphocytes. Typically, a lymphocytosis is observed during and
immediately after exercise, with numbers of cells falling below pre-exercise lev-
els during the early stages of recovery, before steadily returning to resting values.
This pattern of mobilisation is observed for T cells (and T cell subpopulations)
and to a lesser extent, B cells. Changes are proportional to exercise intensity and
duration, although the effect of intensity is more marked (161, 258). Insufficient
recovery between prolonged exercise bouts appears to exaggerate the biphasic
response (251). Mobilization of T and B cell subsets in this way is largely influ-
enced by the actions of adrenaline (epinephrine) both directly on the expression
of cell adhesion molecules particularly those of the integrin and selectin families,
and indirectly via sympathetically mediated influences on cardiac output and the
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Figure 2. Potential mechanisms by which acute and chronic exercise affects
acquired/adaptive immunity. HPA = hypothalamic pituitary adrenal; ACTH = adrenocorti-
cotropic hormone.
subsequent increase in shear stress associated with enhanced blood flow (262)
(Figure 2). Lymphocytes express a high density of β2-adrenergic receptors and the
density of these receptors increases with both exercise and exposure to cate-
cholamines (262). The greatest expression of these receptors is found on the sur-
face of NK cells, with fewer on CD8+ and B cells and least of all on CD4+ cells;
the differing effects of intense exercise on the relative magnitude of mobilization
of the lymphocyte subsets reflects this differential density of adrenergic receptor
expression. The decrease in T cell number following exercise is largely due to a
decrease in type 1 T cells, since intensive physical activity decreases the percent-
age of circulating Type 1 T cells but has little effect on the percentage of circulat-
ing Type 2 T cells (118, 287). It is unclear whether these changes are due to apop-
tosis or, as seems more likely, a redistribution of cells to other compartments. A
decrease in the percentage of type 1 CD4+ and CD8+ T cells alone does not neces-
sarily indicate that defence against intracellular pathogens such as viruses is sup-
pressed; cytokine production is just one step of the multi-stage process that ulti-
mately leads to lymphocyte proliferation or cytotoxicity. It is possible that any
increase or decrease in cell number is countered by a diminished or enhanced
response of other aspects of immune cell function. Moreover, the addition of a
subpopulation of cells from the marginated pool into the circulation in response to
exercise may influence lymphocyte function simply because the mobilized cells
may have different functional abilities to those already in the circulation
(Figure 2).
T and B cell function
T cells play a fundamental role in the orchestration and regulation of the cell-
mediated immune response to pathogens. One important consequence of a defect
in T cell function is an increased incidence of viral infections (63). With this in
mind, it has been speculated that the apparent increased susceptibility of sports-
men and women to upper respiratory tract infections may be due to exercise-
induced decreases in T cell function.
There is evidence that acute exercise stimulates T cell subset activation in vivo
and in response to mitogen- and antigen-stimulation, as assessed by expression of
cell surface markers of T cell activation, including CD69, CD25, the HLA-DR
antigen, CD45RO and CD45RA (84, 86, 100). It is not clear whether such
increases in activation are due to the recruitment of activated cells into the circula-
tion, or are an effect on the state of activation of individual cells themselves.
Most likely it is a combination of both. Numerous studies report decreased mito-
gen- and antigen-stimulated T cell proliferation following acute exercise, but
interpretation of these findings may be confounded by the presence of NK cells
and B cells within the cell cultures; alterations in relative numbers of T, B and NK
cells in blood samples obtained before and after exercise may affect the propor-
tion of cells that can respond to stimulation in a given volume of blood or number
of peripheral blood mononuclear cells (102). Furthermore, in vitro stimulation
with mitogen does not necessarily reflect the more subtle responses of cells fol-
lowing a specific antigen encounter within the body (20). Moreover, exercise may
alter T cell function in vitro through an increase in the rate of apoptosis in cell cul-
ture rather than a decrease in T cell proliferation rate (101).
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Upon stimulation, B cells proliferate and differentiate into memory cells and plas-
ma cells, with plasma cells localised primarily in lymphoid or mucosal tissue and
able to produce and secrete vast amounts of Ig (or antibody) specific to the anti-
gen that initiated the response. The binding of Ig to its target antigen forms anti-
body-antigen complexes; Ig and antibody-antigen complexes circulate in the body
fluids. The effect of exercise on humoral immune function has been assessed
through measurements of serum and mucosal Ig concentration in vivo and serum
Ig synthesis following in vitro mitogen-stimulation. Serum Ig concentration
appears to remain either unchanged, or slightly increased, in response to either
brief or prolonged exercise (184, 203, 229). Mitogen-stimulated IgM concentra-
tion appears to increase in response to exercise independently of changes in T or
B cell number, although there are contrasting findings concerning IgA and IgG
(258, 306).
Consensus: exercise training and acquired immune function
In the true resting state (i.e. more than 24 h after their last training session) circu-
lating lymphocyte numbers and functions of athletes appear to be broadly similar
to those of non-athletes (192). Longitudinal studies in which previously sedentary
people undertake weeks or months of exercise training fail to show any marked
changes in T and B cell functions, provided that blood samples are taken at least
24 h after their last exercise bout. In contrast, T and B cell functions appear to be
sensitive to increases in training load in well-trained athletes undertaking a period
of intensified training, with decreases in circulating numbers of Type 1 T cells,
reduced T cell proliferative responses and falls in stimulated B cell Ig synthesis
reported (7, 139, 308). This suggests that athletes engaging in longer periods of
intensified training can exhibit decreases in T cell functionality. The cause of this
depression in acquired immunity appears to be related to elevated circulating
stress hormones, particularly cortisol, and alterations in the pro/anti-inflammatory
cytokine balance in response to exercise (Figure 2). This appears to result in a
temporary inhibition of Type 1 T cell cytokine production, with a relative damp-
ening of the Type 1 (cell-mediated) response.
Conclusions
Acute intensive exercise elicits a depression of several aspects of acquired
immune function. This depression is transient and cell numbers and functions
usually return to pre-exercise values within 24 h. If recovery between exercise
sessions is insufficient, as during prolonged periods of intensified training in elite
athletes, this temporary decrease in cell function can become a chronic depression
of acquired immunity. Although not clinically immune deficient, it is possible
that the combined effects of small changes in several aspects of host defence may
compromise resistance to minor illnesses, such as respiratory infections. The clin-
ical significance of these alterations requires more detailed investigation.
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MUCOSAL IMMUNITYAND EXERCISE
Background
Mucosal surfaces such as those in the gut, urogenital tract, oral cavity and respirato-
ry system are protected by a network of organised structures known as the Common
Mucosal Immune System (96). These structures include Peyer’s patches and isolated
lymphoid follicles in gut-associated, nasal-associated, and bronchial/tracheal-asso-
ciated lymphoid tissues and salivary glands. The production of immunoglobulin A
(IgA), specifically secretory IgA (SIgA), is the major effector function of the
mucosal immune system, SIgA together with innate mucosal defences such as α-
amylase, lactoferrin and lysozyme, provides the ‘first line of defence’ against
pathogens present at mucosal surfaces. In addition, secretory IgM and locally pro-
duced IgG play a less significant role in protection of mucosal surfaces (96). The
transepithelial transport of the polymeric Ig receptor (pIgR)-IgA complex into secre-
tions such as saliva affords three potential ways in which IgA provides an effective
defence against microbial pathogens: through prevention of pathogen adherence and
penetration of the mucosal epithelium, by neutralising viruses within the epithelial
cells during transcytosis and by excretion of locally formed immune complexes
across mucosal epithelial cells to the luminal surface (138).
Consensus
A high incidence of infections is reported in individuals with selective deficiency
of SIgA (105) or very low saliva flow rates (75). Moreover, high levels of saliva
SIgA are associated with low incidence of URTI (252) and low levels of saliva
SIgA in athletes (64, 95) or substantial transient falls in saliva SIgA (187) are
associated with increased risk of URTI.
Levels of saliva SIgA vary widely between individuals. Although some early
studies indicated that saliva SIgA concentrations are lower in endurance athletes
compared with sedentary individuals (304), the majority of studies indicate that
there are no differences between athletes compared with non-athletes except
when athletes are engaged in heavy training (19, 96).
Falls in saliva SIgA concentration can occur during intensive periods of training
(4, 32, 64, 93, 95, 97, 187, 303, 304) and some studies (32, 64, 93, 95, 187),
though not all (4, 303, 320) have observed a negative relationship between saliva
SIgA concentration and occurrence of URTI. Several of the above cited studies
examined changes in saliva SIgA during intensive periods of military training (32,
303, 320). However, this often involves not only strenuous physical activity, but
also dietary energy deficiency (see section on nutritional countermeasures in part
two of the position statement), sleep deprivation (see section on sleep disruption
in part two of the position statement) and psychological challenges (see section
on the effects of stress on immune function in part two of the position statement).
These multiple stressors are likely to induce a pattern of immunoendocrine
responses that amplifies the exercise-induced alterations (207).
Increases in saliva SIgA have been observed after a period of regular moderate
exercise training in previously sedentary individuals and may, at least in part, con-
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tribute to the apparent reduced susceptibility to URTI associated with regular
moderate exercise (3, 129).
The saliva SIgA response to acute exercise is variable and may be influenced by
exercise mode, intensity and duration as well as the fitness of the subjects,
unstimulated versus stimulated saliva collection methods, how saliva SIgA is
expressed (e.g. absolute concentration, as a secretion rate or as a ratio to total pro-
tein or osmolality) and other factors that may be present such as reduced food
intake, dehydration, sleep deprivation, altitude, and psychological stress (19).
Levels of saliva SIgA are generally unchanged with resistance exercise sessions
(130) and moderate aerobic exercise lasting less than 1 h (19).
The saliva SIgA response to exercise is generally not affected by environmental
temperature (116, 137, 312), short periods (<24 h) of fasting (5) or food restric-
tion (207), carbohydrate intake during exercise (18, 146, 199), up to 30 h of sleep
deprivation (243), or by time of day (4, 57, 145).
Salivary α-amylase is another antimicrobial protein (317) and its secretion is
stimulated by increased activity of the sympathetic nervous system (37), with the
majority of this protein produced by the parotid gland (281). In accordance with
this, several studies have found that exercise increases the α-amylase activity of
saliva in a manner that is dependent on exercise intensity (6, 18, 145, 317).
Controversies
Secretion of saliva and its constituent proteins is regulated by the autonomic nervous
system. The secretion of SIgA in rats can be increased by both parasympathetic and
sympathetic nerve stimulation and adrenaline has recently been shown to increase the
transport of human IgA into saliva by rat salivary cells via increased mobilisation of
the pIgR (33, 34). Since intensive exercise is associated with enhanced sympathetic
nervous system activation, it seems surprising that some studies report a decrease in
saliva SIgA concentration following a bout of high intensity exercise (>80%V.O2max)
that recovers to resting levels within 1 h of exercise completion (154, 164). Other
studies have reported either no change (163, 243, 299) or increases (6, 23, 313) in sali-
va SIgA concentration after single or repeated bouts of high intensity exercise.
Saliva SIgA concentration (or secretion rate) in response to prolonged (>1.5 h)
moderate intensity exercise (50-75%V.O2max) is more consistently reported to
decrease (153, 199, 213, 288, 304) or remain unchanged (23, 116, 163, 195, 255).
Different methods of saliva collection and differences in hydration status of sub-
jects may contribute to the discrepancies in the literature (19, 144, 207, 291).
A few small-scale studies have reported that female athletes have lower saliva
SIgA concentration (95) and secretion rate (4, 5) compared with their male coun-
terparts, but confirmation of this possible gender difference is required in a larger
subject population.
There is little data available regarding changes in salivary lysozyme and lactofer-
rin concentrations with acute or chronic exercise, although intense and exhaustive
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exercise of both short and long duration is associated with increases in salivary
lysozyme (6, 316, 317) and lactoferrin secretion (316). These effects also appear
to be dependent on exercise intensity, since no change was seen following ~20
min of cycling at 50%V.O2max (6). Prolonged cycle ergometer exercise at
60%V
.
O2max caused a significant increase in salivary α-defensin concentrations
and secretion rates (53).
The mechanisms by which exercise influences salivary responses remain to be
fully elucidated (Figure 3). The rate of secretion of saliva SIgA is dependent on
the production of IgA by the plasma cells in the submucosa and/or the rate of IgA
transcytosis across the epithelial cell which is determined by the availability of
the pIgR (24). The time-course (minutes) of the alterations in saliva SIgA secre-
tion that are observed in response to acute exercise suggest that this is the princi-
pal mechanism by which acute intensive exercise influences saliva SIgA secre-
tion. In anaesthetised rats, acute stimulation of β-adrenoreceptors above a certain
threshold increases saliva SIgA secretion in a dose-independent manner via ele-
vated transcytosis from the glandular pool (230) and this is associated with
increased availability of the pIgR (34). Although such a mechanism has not yet
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been demonstrated in humans, the finding that increases in saliva SIgA secretion
rate are associated with elevations in plasma adrenaline following caffeine inges-
tion lends some support to this suggestion (21).
Although enhanced IgA transcytosis probably accounts for elevations in saliva
SIgA secretion observed after exercise, it cannot account for the findings of
either no change or decreases in saliva SIgA secretion rate with intense physical
activity. The observation that increased mobilisation of the pIgR only occurred
above a certain threshold frequency of stimulation (230) could account for the
finding of little change in saliva SIgA levels at more moderate intensities of exer-
cise. However, the finding of decreased concentrations of saliva SIgA in
response to acute exercise is harder to explain. Nevertheless, a study in rats
demonstrated that following a prolonged treadmill run to exhaustion, decreases
in saliva SIgA concentration were associated with a decline in pIgR mRNA
expression (127). Although highly speculative, this might imply that there is a
second critical threshold (or duration) of stimulation, above which pIgR expres-
sion becomes downregulated.
It is unlikely that cortisol plays a major role in the regulation of saliva SIgA secre-
tion in response to acute exercise, because changes in both saliva SIgA concentra-
tion and secretion rate have been observed in the absence of any alterations in
plasma or salivary cortisol (6, 145, 146, 256, 299) and there appears to be no cor-
relation between saliva SIgA and cortisol responses to exercise (164).
Modification of IgA synthesis could play a major role in the changes in saliva
SIgA secretion observed in response to long term intensive training and chronic
psychological stress (19, 24, 226). In addition, it may be that repeated mobilisa-
tion of the pIgR could deplete the available formed IgA pool, leading to decreases
in saliva SIgA output. However, to date there is scant research in either animals
or humans to support these speculations.
Conclusions
To date the majority of exercise studies have assessed saliva SIgA as a marker of
mucosal immunity but more recently the importance of other antimicrobial pro-
teins in saliva including α-amylase, lactoferrin and lysozyme has gained greater
recognition. Acute bouts of moderate exercise have little impact on mucosal
immunity, but very prolonged exercise and periods of intensified training can
result in decreased saliva secretion of SIgA. Mechanisms underlying the alter-
ations in markers of mucosal immunity with acute exercise are probably largely
related to the activation of the sympathetic nervous system and its associated
effects on salivary protein exocytosis and IgA transcytosis. Depressed secretion of
SIgA into saliva during periods of intensified training and chronic stress are likely
linked to altered activity of the hypothalamic-pituitary-adrenal axis, with inhibito-
ry effects on IgA synthesis and/or transcytosis. There is reasonable evidence to
indicate that reduced levels of saliva SIgA are associated with increased risk of
URTI.
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IMMUNOLOGICAL METHODS IN EXERCISE IMMUNOLOGY
Background
There are many examples in the literature and reviewed in this consensus paper
that acute exercise and exercise training can alter host defence, leading to changes
in disease susceptibility and severity. One important mechanism for such changes
is alterations in immune function. Herein lies a primary challenge for exercise
immunologists; how does one measure immune function in a meaningful way?
The immune system is comprised of a large variety of cells, occurs in diverse tis-
sues (i.e., lymph node, Peyer’s patches, spleen and liver), and involves the orches-
tration of hundreds of soluble and cell membrane associated proteins. Successful
host defence is the end product of these responses.
Consensus
Exercise immunology experiments test the impact of acute exercise and/or regular
exercise training on a number of measures of the immune system. The types of
immunological assessments most commonly reported, especially in the human
exercise studies involve analyses of blood borne circulating immune proteins
(e.g., interleukin (IL)-6, IL-1β, C-reactive protein, IL-8, tumour necrosis factor
alpha (TNFα) chemokines), circulating blood leukocytes (e.g., CD4+ T cells,
CD8+ T cells, Th1, Th2, Th17, Treg, B cells, neutrophils, monocytes), and sali-
vary/plasma antibody or immunoglobulin (Ig) concentrations. Some studies docu-
ment dynamic changes in the composition of blood leukocyte populations (e.g.,
decreases in peripheral blood CD4+ T cells and increases in neutrophils), and
some studies isolate the peripheral blood leukocytes and put them in culture with
various exogenous stimuli, such as mitogens, that stimulate large populations of
immune cells to produce immune products. Using these types of measures, there
are many reported examples of robust dynamic changes produced both with acute
exercise and after exercise training. As discussed in other sections of this position
statement, the nature of the reported changes measured depends on a number of
variables that include the training status of the individual, the intensity of the
exercise bout, the nutritional status of the individual, the timing of the
blood/saliva sample collection and the nature of the specific immunological
measure. Due to the reported dynamic changes in such blood borne and salivary
measures, it is essential that multiple samples are taken, including pre-, during-,
and post- exercise timepoints. Non-exercised, time-matched controls must also be
sampled to control for circadian, seasonal, and environmental changes in these
dynamic measures. The majority of studies in exercise immunology are sensitive
to these aspects of experimental design, making these methodological features
strengths of the field.
Another approach to assessing immune function extends beyond blood or salivary
soluble proteins, circulating cells, total Ig or in vitro stimulated responses. It
involves challenging experimental subjects with antigenic (immune stimulating,
not disease capable) or pathogenic (immune stimulating, possible disease produc-
ing) stimuli and assessing relevant antigen-driven responses including antigen
specific cell-mediated delayed type hypersensitivity (DTH) responses or antibody
responses and in some instances, changes in disease susceptibility, duration, and
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severity. This approach allows assessment of in vivo immune function and has
several advantages over the previously described measures. Firstly, the genera-
tion an antigen specific Ig response reflects a functionally important end product
of a multicellular in vivo immunological response. For example, the generation of
a primary antibody response to a novel antigen like keyhole limpet haemocyanin
(KLH) requires antigen presentation (likely by a B cell given KLH is a low dose
soluble protein) to CD4+ T cells. KLH specific T cells then provide T cell help in
the form of both co-stimulation and cytokines to KLH specific B cells to stimu-
late the production of anti-KLH IgM and promote isotype switching to anti-KLH
IgG1 (driven by Th2 cytokines) and IgG2a (driven by Th1 cytokines). If an acute
exercise bout or exercise training impacts in vivo immune function, then changes
in the generation of KLH specific Ig will be detected. In addition, if there are
selective changes in isotype switching, for example an impact on anti-KLH IgG1
and not on anti-KLH IgG2a, or vice versa, this suggests selective effects on Th1
and Th2 responses (70, 88, 159, 177). This approach has been successfully used
in both humans (274, 275, 278) and animals (55, 69, 71, 82, 179, 311).
The results of the exercise immunology studies that measure in vivo anti-KLH Ig
responses support the general conclusion that an acute bout of intense exercise
suppresses anti-KLH Ig production (178), however, moderate exercise training
can restore optimal antibody in the face of stressors (69, 72) and ageing (99, 277).
Interestingly, the majority of studies using this measure rarely demonstrate an
increase in the anti-KLH Ig response with exercise training in young healthy
adults. This is likely due to the fact that young healthy sedentary and physically
active organisms already possess excellent immune responses, and elevating that
response further is not necessarily a good thing. Too much immunity is just as
detrimental as too little (Figure 4). In other words, the positive effects of exercise
training on immune function and host defence may be most readily revealed when
in vivo immune function is
sub-optimal consequent to
ageing, stress, or other fac-
tors. In fact there are several
papers that demonstrate that
regular physical activity
reduces incidence of illness
only if people report high
levels of stress (26, 74).
A related approach that also
measures in vivo immune
function, and is reported in
the exercise immunology lit-
erature is to inject not a
novel antigen, such as KLH,
but rather a mixture of anti-
gens using influenza vaccine or tetanus vaccine that usually contain a subset of
repeated antigens that have been “seen” by people before (30, 60, 61). The
advantage of this approach, especially when studying humans, is that people are
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Optimal Immunity-Disease Protection
Elevated Immunity-Disease Susceptibility 
(allergy, hypersensitivity, autoimmunity)
Suboptimal Immunity-At Risk
Compromised Immunity-Disease Susceptibility
Suboptimal Immunity-At Risk
Figure 4. Exercise associated changes in immune func-
tion have greatest effects on host defence and disease
susceptibility/severity, if the individual has suboptimal
immune function due to ageing, stress or other factors.
willing to receive such injections because they produce useful immunity against
influenza and/or tetanus. The disadvantage of this approach is that the subsequent
antibody response is a mixture of primary, secondary and tertiary responses. This
makes it difficult to accomplish the following: 1) measure group changes in iso-
types (very little IgM is detectable in secondary and tertiary versus primary
responses); 2) compare concentrations of antigen specific antibody (secondary
and tertiary responses characteristically produce higher levels of IgG than pri-
mary responses); and 3) make inferences about cellular mechanisms for any
detected changes (unique cellular and co-stimulatory signals are required for pri-
mary versus secondary and tertiary responses)(70). Thus the assessment of an
antigen-specific immune response following vaccination yields important infor-
mation about in vivo immune responses that are superior to measuring dynamic
circulating protein or cell changes, but suffers some interpretive limitations not
found after primary antigenic challenge.
An additional methodological and interpretation challenge when studying exer-
cise-induced changes in immune responses is to determine if the measured
changes in immunity are sufficient to alter host defence or disease susceptibili-
ty/severity. This is a complex challenge. It involves issues associated with
immune safety net and redundancy (Figure 4) and immune response specificity
relative to host disease defence. Because immune function is critical to host sur-
vival, the system has evolved a large safety net and redundancy such that it is dif-
ficult to determine how much immune function must be lost or gained to incur
changes in host disease susceptibility. Studies on human immunodeficiency
(HIV) patients offer insight into the issue. It is commonly reported that patients
with HIV must lose at least ~50-60% of their total circulating CD4+ T cells
before an increase in the incidence of opportunistic infection occurs (182). There
are numerous examples of exercise altering circulating cell numbers and other
measures of immunity, often by 15-25%. Whether changes of this magnitude are
sufficient to alter disease susceptibility or severity likely depends on the state of
the host. If, for example, immune function was optimal or functioning at 100%
then ± 15-25% change may not impact host defence in a clinically significant
way, because the safety net for immune function is great. If instead immune func-
tion was suboptimal due to ageing, stress or other factors placing host immunity
in the “at risk zone”, then a 15-25% change in immune function could have sig-
nificant consequences for host defence (Figure 4). A second issue to consider
when interpreting the functional significance of changes in immune measures for
host defence is response specificity. That is, what specific types of pathogens or
disease states could be impacted by changes in the aspects of immunity meas-
ured? For example, how would transient changes in circulating T cell numbers
influence anti-viral host defence? This issue is especially challenging for human
research. There are, however, several rodent disease models that establish clear
links between changes in specific immune responses and corresponding changes
in host defence and disease severity. Work by Shamgar Ben-Eliyahu is one exam-
ple (12). Although he is not specifically testing the impact of exercise, he is
exploring the impact that other stressors (i.e., surgery, drugs etc.) have on immune
function and host defence. A strength of his model is that he both demonstrates
stress-associated suppression in NK cell tumour killing ex vivo and stress-associ-
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ated increases in tumour load in vivo (14). Furthermore he has verified that the
tumour tested in these studies is primarily killed by NK cells and not CD8+ T
cells (13). Thus using this type of approach one can measure immune function
and verify relevance for host defence and disease susceptibility/severity.
A second approach used in immunology research involves challenging animals
with pathogens that require specific and well-characterized immunological
responses for survival. Leishmania major, for example, requires a Th1 dominant
response for effective host defence (43). If one blocks the development of Th1
responses, the animal will die. This is a useful experimental model, because one
can link changes in specifically Th1 responses (cytokines, clonal expansion, Th1
differentiation or activation, etc.) with corresponding changes in Leishmania dis-
ease susceptibility, severity and host survival. This type of model could be imple-
mented in exercise immunology studies.
Controversies and future directions
Most studies in exercise immunology are conducted in humans and are usually
limited to immune measures derived from the blood, such as soluble immune pro-
teins, cell numbers, in vitro cellular responses to mitogen and total Ig concentra-
tions. As previously discussed, it is difficult to determine how such changes could
impact host defence, disease susceptibility or severity. Although persistent or
chronic elevations in blood concentrations of inflammatory proteins may be
reflective of changes in inflammatory processes, it is possible that dynamic, short-
lived changes in blood borne immune factors offer little insight into how the in
vivo immune function and/or host defence is altered. In addition, increases in con-
centrations of blood borne soluble proteins such as IL1β, IL8, and TNF-α that
classically play a role during local tissue inflammation, likely are not related to
tissue inflammation. There is no evidence that the acute increases in circulating
concentrations of these proteins produced by stressors or exercise function to
modulate any inflammatory process, especially in an otherwise healthy host.
More likely, the acute elevations in IL-6 and IL1-β found after exercise may be
more important for the metabolic rather than the immunological, responses to
exercise.
Given the pleiotropic and context dependent nature of cytokines/chemokines, per-
haps we should revise our thinking when trying to interpret acute and dynamic
effects of exercise. Firstly, we need to consider any change in cytokine concentra-
tion within the context of the cytokine network (180). In other words, the contex-
tual dependence of cytokines cannot be ignored. A nice immunological example
of contextual dependence is the effect of transforming growth factor (TGF)-β on
CD4+ T cell differentiation. Based on the 3-signal model of T cell activation and
differentiation (45), cytokines play a pivotal role in CD4+ T cell differentiation
after activation from Th0 (non-polarized) to Th1, Th2, Treg etc. TGF-β plus IL6,
for example, drives the differentiation of the Th0 toward a Th17 cell. In contrast,
TGF-β in the absence of IL-6 drives the differentiation of the Th0 toward a Treg
cell. A second example of cytokine networks and context dependence can be
found in the exercise immunology literature, where increases in circulating IL-6
in the presence of TNF-α is indicative of inflammation, whereas increases in cir-
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culating IL-6 in the absence of TNF-α may be indicative of increased energy
demand (217, 219)(Figure 6).
In conclusion, there are clear effects of both acute exercise and exercise training on
measures of immune products and function. Exercise training effects on immune
function and host defence are especially demonstrable when immune function is not
optimal due to ageing, stress or other factors. Exercise immunology researchers are
faced with challenges associated with both the immune measures and the interpreta-
tion of changes in such measures. In vivo antigen specific immune function can be
measured by injecting subjects (both people and animals) with novel antigens and
vaccination antigens; assessment of antigen specific immunoglobulin and T cell (by
DTH tests) responses is a strong approach. The ability to predict if any change in
antibody titre or T cell function is sufficient to alter host defence, specific disease
susceptibility or disease severity however, remains debatable.
ANTI-INFLAMMATORY EFFECTS OF PHYSICALACTIVITY
Chronic inflammation is involved in the pathogenesis of insulin resistance, ather-
osclerosis, neurodegeneration, and tumour growth. Evidence suggests that the
protective effect of exercise may, to some extent, be ascribed to the anti-inflam-
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Figure 5. Hypothesis: Physical inactivity leads to accumulation of visceral fat and conse-
quently to the activation of a network of inflammatory pathways, which promotes develop-
ment of insulin resistance, atherosclerosis, neurodegeneration, and tumour growth, leading
to the development of “the diseasome of physical inactivity”.
matory effect of regular exercise, mediated via a reduction in visceral fat mass
and/or by induction of an anti-inflammatory environment with each bout of exer-
cise.
Background
It is well-established that physical inactivity increases the risk of type 2 diabetes
(305), cardiovascular diseases (204), colon cancer (322), breast cancer (175),
dementia (253) and depression (211). Physical inactivity leads to the accumula-
tion of visceral fat and consequently the activation of a network of inflammatory
pathways. Chronic inflammation promotes the development of insulin resistance,
atherosclerosis, neurodegeneration, and tumour growth (104), and subsequently
the development of a number of diseases associated with physical inactivity (218)
(Figure 5).
The protective effect of exercise against chronic inflammation associated diseases
may, to some extent, be ascribed to an anti-inflammatory effect of regular exercise.
Several studies show that markers of inflammation are reduced following longer-
term behavioural changes involving reduced energy intake and increased physical
activity (reviewed in (225)). We suggest that the long-term anti-inflammatory
effects of exercise may be mediated both via a reduction in visceral fat mass and
the establishment of an anti-inflammatory environment with each bout of exercise.
Consensus
We have suggested that cytokines and other peptides that are produced, expressed,
and released by muscle fibres and exert paracrine or endocrine effects should be
classified as "myokines" (218). Such myokines may exert a direct effect on fat
metabolism and thereby result in indirect anti-inflammatory effects. Moreover,
myokines may exert direct anti-inflammatory effects or stimulate the production
of anti-inflammatory components.
It is suggested that contracting skeletal muscles release myokines, which work in
a hormone-like fashion, exerting specific endocrine effects on visceral fat and
other ectopic fat deposits. Other myokines work locally within the muscle via
paracrine mechanisms, exerting their effects on signalling pathways involved in
fat oxidation.
The first identified and most studied myokine is the gp130 receptor cytokine,
interleukin (IL)-6. A number of studies during the past decade have revealed that
both type I and type II muscle fibres express the myokine IL-6 in response to
muscle contractions. Subsequently IL-6 exerts its effects both locally within the
muscle (e.g. through activation of 5’ adenosine monophosphate activated protein
kinase, AMPK) and, when released into the circulation, in a hormone-like fash-
ion in a number of organs. Within skeletal muscle, IL-6 acts locally to signal
through a gp130Rβ/IL-6Rα homodimer resulting in activation of AMPK and/or
phosphatidylinositol-3-kinase (PI3K) to increase fat oxidation and glucose
uptake (219). Although it has not been demonstrated that IL-6 has specific effects
on visceral fat mass, it does appear to play an important role in lipid metabolism.
IL-15 is expressed in human skeletal muscle and has been identified as an anabol-
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ic factor in muscle growth. In addition to its anabolic effects on skeletal muscle in
vitro and in vivo, IL-15 appears to play a role in lipid metabolism (191). Therefore,
IL-15 has been suggested to be involved in muscle – fat cross talk. IL-15 mRNA
levels are upregulated in human skeletal muscle following a bout of strength train-
ing (190), suggesting that regular training may lead to IL-15 accumulation within
muscle. Interestingly, we demonstrated a decrease in visceral fat mass, but not sub-
cutaneous fat mass, when IL-15 was overexpressed in murine muscle (189).
The cytokine response to exercise differs from that elicited by severe infections
(Figure 6). Classical pro-inflammatory cytokines, tumour necrosis factor alpha
(TNF-α) and IL-1β, in general do not increase with exercise, indicating that the
cytokine cascade induced by exercise is markedly different from the cytokine cas-
cade induced by infections, (reviewed in (219)).
To study whether acute exercise induces an acute anti-inflammatory response, a
model of “low grade inflammation” was established in which a low dose of E.
coli endotoxin was adminis-
tered to healthy volunteers,
randomised to either rest or
exercise prior to endotoxin
administration. In resting
subjects, endotoxin induced
a 2 to 3 fold increase in cir-
culating levels of TNF-α. In
contrast, when the subjects
performed 3 h of ergometer
cycling and received the
endotoxin bolus at 2.5 h, the
TNF-α response was totally
blunted (284). This study
provides some evidence that
acute exercise may inhibit
TNF-α production.
Typically, IL-6 is the first
cytokine released into the
circulation during exercise.
The level of circulating IL-6
increases in an exponential
fashion (up to 100 fold) in
response to exercise and
declines in the post-exercise
period. The circulating levels
of well-known anti-inflam-
matory cytokines such as, IL-
1ra and IL-10, also increase
after exercise. However, the
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Figure 6. Comparison of sepsis-induced (A) versus exer-
cise-induced (B) increases in circulating cytokines. Dur-
ing sepsis, there is a marked and rapid increase in circu-
lating TNF-α, which is followed by an increase in IL-6. In
contrast, during exercise the marked increase in IL-6 is
not preceded by elevated TNF-α (220).
appearance of IL-6 in the circulation is by far the most marked and its appearance
precedes that of the other cytokines. A number of studies have demonstrated that
contracting skeletal muscle fibres per se produce and release IL-6. Of note, IL-6
infusion totally mimics the acute anti-inflammatory effects of a bout of exercise
both with regard to induction of IL-1ra and IL-10 and with regard to suppression
of endotoxin-stimulated increases in TNF-α levels. During acute exercise there is
also a marked increase in adrenaline (epinephrine), cortisol, growth hormone,
prolactin, and other factors that have immunomodulatory effects (104, 193).
Taken together, it appears that each bout of exercise induces an anti-inflammatory
environment.
Controversies
Patients with chronic inflammatory diseases such as type 2 diabetes are often pre-
scribed exercise to improve quality of life; however, the use of exercise as a treat-
ment for these diseases remains controversial. A systemic review has highlighted
that acute and chronic exercise may elicit different responses in patients with
chronic inflammatory disease when compared with healthy controls (227). For
example, it has been reported that in patients with chronic obstructive pulmonary
disease plasma TNF-α levels were abnormally increased compared with healthy
controls following moderate-intensity exercise (236). Therefore, more needs to be
understood about the nature of exercise that has anti-inflammatory effects in
patients with chronic inflammatory diseases without increasing the underlying
inflammatory pathology of the disease.
Future directions
To understand the mechanism of the protective, anti-inflammatory effect of exer-
cise fully, we need to focus on the nature of exercise that is most effective at
allieviating the effects of chronic inflammation in disease. The beneficial effects
of endurance exercise are well known; however, the anti-inflammatory role of
strength training exercises is poorly defined and remains an area for future inves-
tigation. In addition, the independent contribution of an exercise-induced reduc-
tion in visceral fat versus other exercise-induced anti-inflammatory mechanisms
needs to be better understood.
EXERCISEAND CANCER
Background
Exercise can have a beneficial role in cancer prevention and therapy. Determining
if regular physical activity reduces cancer risk through immunological mecha-
nisms is of public health relevance and could lead to tailored and novel exercise
prescriptions.
Consensus
The incidence of several types of cancer is reduced by regular physical activity.
Comprehensive reviews by the International Agency for Research on Cancer (17)
and the World Cancer Research Fund (330) identified an independent protective
effect of physical activity on colon and postmenopausal breast cancer risk. Evi-
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dence is also mounting that physical activity reduces risks of endometrial, lung,
and pancreatic cancers.
Physical activity has a therapeutic effect in cancer patients by reducing cancer
recurrence, enhancing health outcomes, and increasing survival. Women who
exercised moderately prior to (81), and after a breast cancer diagnosis, had signif-
icant improvements in overall and disease-specific survival and quality of life
compared to sedentary counterparts (280, 318). Protective effects of physical
activity have also been observed for colorectal cancer patients (169).
There are fewer reports on exercise and neoplasia in animals with chemically-
induced, transplantable, or spontaneous tumours (111). These studies describe
exercise protecting against intestinal tumour incidence or number, although
results with Apcmin mice, which develop intestinal tumours spontaneously, have
been less consistent (10). A beneficial effect of exercise on mammary tumour
incidence, multiplicity, growth rate and/or survival has also been reported (249).
Controversies
The biological mechanisms relating exercise and cancer are not well understood.
Potential mediators include reductions in body mass and/or adiposity, decreases
in reproductive hormone levels, altered growth factor milieu, enhanced antioxi-
dant defence mechanisms, and changes in immune function, including reduced
inflammation and enhanced anti-tumour immunity. Mechanisms studied in detail
in humans have not been studied in animal models, and vice versa. Therefore, the
relative contribution of these mechanisms in specific cancer types remains
unknown. With respect to the hypothesis that exercise induces alterations in
immune mediators, more is known about exercise-induced changes in inflamma-
tory mediators than about changes in specific anti-tumour mechanisms; however,
controversies exist for both hypotheses.
The association between chronic inflammation and cancer is well established
(46). Human cross-sectional studies demonstrate an inverse relationship between
regular physical activity and inflammatory biomarkers, including C-reactive pro-
tein (CRP), tumour necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) (123,
225). Reductions in CRP levels with exercise training have also been reported
(123). Although exercise may reduce inflammatory biomarkers, clinical trials
indicate variable outcomes, with an effect of exercise on CRP in some but not all
studies (231). Less work has been done with IL-6 in humans, but again there are
conflicting results (319). Finally, a recent randomized trial on markers of inflam-
mation following a 12-month exercise intervention reported no change in partici-
pant colonic prostaglandin levels (1).
Animal studies demonstrate an anti-inflammatory role of exercise via multiple
pathways. Exercise normalized the elevated levels of TNF-α in soluble TNF-
receptor knock-out mice (126). Freewheel training lowered TNF-α expression
and increased expression of antioxidant enzymes in mouse intestinal T lympho-
cytes (112, 113) and decreased prostaglandin E2 level in the serum and polyps
from Apcmin mice (121). Treadmill exercise decreased the number of
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macrophages in polyps from Apcmin mice (8), and swimming exercise in rats
reduced COX-2 positive cells in colonocytes (54). Taken together, several inflam-
matory pathways may be altered by exercise, but it is unclear to what extent and
under what physiological conditions these changes occur.
Macrophages and natural killer (NK) cells have been studied in both tumour-bear-
ing and healthy subjects following exercise. Collectively, animal model data show
a positive effect of exercise on macrophage function, with enhanced clearance of
lung metastases (324). Additionally, training results in greater in vitro NK cell
cytotoxicity (221, 248), enhanced in vivo mechanisms of natural immunity and
reduced pulmonary tumour metastases in mice (155, 221); however, these effects
are small and modified by exercise intensity and timing. No change in NK cell
cytotoxicity was observed following a 12-month walking intervention in healthy
postmenopausal women (31). There are fewer studies on exercise and antigen-
specific T cell functions. Moderately active older adults have higher influenza-
specific in vitro peripheral blood mononuclear cell proliferation (132) and greater
in vivo delayed type hypersensitivity (DTH) responses (277) compared with
sedentary individuals. Moderate exercise also enhances antigen-specific T-cell
mediated cytokine production and proliferation following vaccination (131, 250).
Exercise improves antigen-specific T cell function, which may translate into bet-
ter protection from infectious agents and greater immunosurveillance. Clinical
and epidemiological studies show that the incidence of upper respiratory tract
infections is lower in moderately active individuals compared with their sedentary
counterparts (42). Although no T cell responses were measured, adequate adap-
tive immune responses play a critical role in the clearance of viral infections of
the respiratory tract (323). The potential importance of adaptive immune respons-
es in relation to exercise and virally-induced cancers cannot be overstated. For
example, cervical cancer of which nearly all cases are due to human papillo-
mavirus (HPV) is one of the leading causes of cancer death among women world-
wide. However, no studies have examined the effect of exercise on the genera-
tion of HPV-specific T cells or the role of exercise in minimizing the immunosup-
pressive environment created by the presence of the tumour.
If an exercise-induced enhancement of anti-tumour mechanisms occurs, protec-
tion should be evident for lymphomas, due to the greater role of immune media-
tion. Only three studies have examined the relationship between physical activity
and Hodgkin’s and non-Hodgkin’s lymphomas (HL, NHL, respectively). Partici-
pation in collegiate sports was associated with a trend to reduced risk of HL,
although this did not reach statistical significance (212). Women who participated
in strenuous physical activity at various time points in adult life had a lower risk
of HL (125). Yet, a case-control study on NHL and occupational physical activity
(measured as energy expenditure or sitting time) found no significant association
(333).
The hypothesis that exercise-mediated changes in immunity contribute to a reduc-
tion in cancer risk is prevalent. For example, women participating in a US nation-
al sample believed the causes of breast and colon cancers were due to changes in
one’s immune system (60% of the sample) and lack of exercise (35-45% of the
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sample) (314). Nevertheless this hypothesis is based on limited evidence (168)
and many studies have significant methodological limitations (283).
Future directions
Physical activity is beneficial in preventing some cancers, and in decreasing
recurrence, increasing survival, and improving quality of life for cancer patients.
Multiple biological pathways may be involved, including a reduction in inflam-
mation and an enhancement of anti-tumour immunity. Neither of the aforemen-
tioned mechanisms has been studied in adequate detail to gain a full understand-
ing of their role in cancer prevention and therapy with respect to exercise. Inflam-
matory mediators have many physiological, metabolic and immunological roles
and are produced in many tissues. Numerous cell types of the innate and adaptive
immune system work in partnership to generate anti-tumour host responses.
Additional studies will be needed to determine a) which inflammatory mediators
and anti-tumour immune mechanisms are most sensitive to exercise, b) the dose,
duration and frequency of exercise needed to achieve anti-inflammatory or anti-
tumour effects, and c) the timing of sample collection with respect to the exercise
bout to adequately capture appropriate levels of anti-inflammatory mediators and
anti-tumour immune mechanisms.
Several technical limitations also need to be addressed. We suggest that the devel-
opment of more sophisticated animal models is required. Although carcinogen-
induced tumours have provided valuable insights, they are limited in that these car-
cinogens induce mutations at multiple genetic loci (117) and trigger both inflam-
mation and immunosuppression (296). In contrast, spontaneous tumour models
which ‘mimic’ human cancers are often limited to single mutations/pathways (i.e.,
ras, p53, APC,Wnt) and do not reflect complex multi-gene-environment (exercise)
interactions. Additionally, many functional immunoassays require fresh cells and
hours of assay preparation. Such immune readouts are difficult in epidemiological
studies; while cryoprotectants allow freezing of immune cells for later analysis,
viability comparisons to fresh cells are often not performed. Functional
immunoassays could be conducted using lymphoid tissue harvested from animals,
but relevant preclinical immunogenic tumour models would be required.
Concluding position
There is consensus that exercise training protects against some types of cancers.
Training also enhances aspects of anti-tumour immunity and reduces inflammato-
ry mediators. However, the data linking immunological and inflammatory mech-
anisms, physical activity, and cancer risk reduction remains tentative.
“OMICS” IN EXERCISE
Background and consensus
“Omics” is the circumspanning word for technologies which try to analyze an
entire biologic field or large parts of it, using high throughput laboratory methods
and correspondingly complex, high end- statistics. Accordingly, analysis by the
“Omics approach” is often hypothesis free (non-targeted), and provides extremely
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detailed and dense information, with a good chance of detecting unexpected
responses or biological pathways. Exercise immunologists hope that “omics” will
help them to gain a better understanding of mechanisms related to talent identifi-
cation, exercise-induced disorders, modulation of the immune system by exercise,
and prevention of diseases by exercise training. They also hope that “omics” can
be used as a tool for optimizing individual training programmes.
Genomics, proteomics, and metabolomics, the classical three, appeared in this
order according to the availability of high-throughput/ high-sensitivity methods.
There is also diversification and refocusing into transcriptomics, spliceomics,
lipoproteomics, pharmacoproteomics, interactomics, and, notably, exerciseomics.
Targets of analysis are the genome itself (alleles, single nucleotide polymor-
phisms, methylations), gene expression (transcription), post-transcriptional regu-
lation (microRNAs), abundance of proteins or metabolites and isomeric shifts and
post-translational modifications.
Results on genome-wide screening for allotypes and single nucleotide polymor-
phisms associated with performance, fitness, or proneness to disease cannot be
considered extensively here. Of special interest for exercise immunology are
results on diabetes type-2, where at least 11 genes have been associated with the
condition, including peroxisome proliferator-activated receptor delta, which is
responsive to types/levels of lipids, and the fat mass and obesity associated (FTO)
risk allele, which may not be responsible for reduced physical activity, but effects
of which can be attenuated by exercise (see reviews (67, 241)).
To our knowledge, gene expression profiling was applied to exercise first in 2002,
with work on rat muscle (39), hippocampus (174), and heart (56). A number of
genes related to cell growth, signal transduction, calcium-flux, synaptic traffick-
ing, or myosin light chains were found to be altered, some were new, some corre-
sponding to previous findings, some were contradictory.
In humans, Mahoney et al. (158) defined a row of genes associated with muscle
growth, remodeling and stress management following eccentric exercise (sterol
and lipid metabolism, insulin and calcineurin pathways, c-myc and jun-D). Tha-
lacker-Mercer et al. (297) exposed young and old adults to moderate exercise-
induced muscle damage, and found vast differences in transcript activation, allud-
ing to an undue inflammatory response in older subjects.
As first proposed by Fehrenbach et al. (66), many studies have now used peripher-
al blood gene expression fingerprinting/clustering for analysis of the effects of
exercise. Types of exercise ranged from 30 min at 80% V
.
O2max (44) to a half-
marathon (334, 335) and heat injury in exercising military recruits (279). Time
points chosen and platforms used for analysis also varied widely.
Special questions addressed by intervention or design were the effects of different
workloads (29, 124), cell fractionation (183, 239), gender and age (205, 237,
238), as well as comparisons of immune suppressed patients versus healthy indi-
viduals (135), with every paper using different challenges and time kinetics.
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Genes that were activated or suppressed showed remarkably little overlap
between studies and between different times. Nevertheless, a number of pathways
involved were identified albeit in different composition. They were related to
stress genes and heat shock proteins (29, 44, 205, 279, 335), interferon (279), sig-
nal transduction (279, 334, 335), pro- and anti-inflammation (29, 44, 110, 135,
205, 237, 239, 279, 297, 334, 335), anti-oxidative system (334, 335), cell growth
and wound healing (44, 237, 239, 297), apoptosis (29, 135, 237-239) and necrosis
(297), neurotransmitters (124), immunity with natural killer cell activity (183,
237, 238), antigen processing and receptor signaling (239), asthma (107, 205,
237, 239) and arthritis (239).
MicroRNAs (miRNAs) are a large family of 21-22 nucleotide non-coding RNAs
with presumed post-transcriptional regulatory activity. miRNA genes were for-
merly misperceived as junk-DNA, but are now recognized as important regulators
of translation. Drummond et al. (58), Safdar et al. (254), and Radom-Aizik et al.
(240) all found a number of miRNAs were increased following exercise and
linked to adjustment of inflammation (240, 254). They also found dysregulation
of exercise reactive miRNA (primary miRNA up, mature down) in aged subjects
(58). An overview is given in Exercise Immunology Review, volume 16 (315).
Proteomics were applied to analyze the effects of exercise on rat heart (28), rat
infarcted cerebellum (172), human muscle (108, 114), human plasma (332) and
pig lipoproteins (244). Changes in expression of myofibrillar proteins, fatty acid
metabolism, novel phosphorylation sites (28), and isoelectric species (114) were
identified, shedding new light on the role of post-translational modification of
proteins. Anti-inflammatory modification of serum complement through moder-
ate exercise was shown (332), and a novel theory of lipoprotein structure includ-
ing novel markers for vascular disease was proposed (244).
A rapidly increasing number of studies have analyzed the metabolome in relation
to exercise - with circumstantial and limited relations to exercise immunology.
Potential biomarkers of strenuous exercise and a strategy for analysis of complex
data sets were proposed by Pohjanen et al. (228). Evaluating the effects of nutritive
interventions in relation to exercise, subjects could be separated according to type
of beverage, training, fitness stage and signs of insulin resistance (41, 142, 170,
331). Dampening of exercise-induced oxidative stress in human erythrocytes by
administration of N-acetyl cysteine was shown (142). Finally, a role for endoge-
nous medium chain acylcarnitines in lipid oxidation was proposed (143).
Consensus: “omics” in exercise
• There is a rapid activation and deactivation of genes in peripheral blood even
after a short bout of exercise (44).
• Clustering is possible and cellular shifts due to exercise are reflected by the
changes in the gene expression profile when using whole blood or peripheral
blood mononuclear cells (66, 135, 183, 334).
• Gene expression is workload dependent; a secondary response by different
genes is detected up to 24 h following exhaustive exercise only (29, 124, 208).
• Expression is influenced by age, and menstrual cycle (205, 237, 238, 297).
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• Gene expression profile differences are in line with pathophysiological find-
ings that could explain exercise-induced asthma (107).
• Immuno-suppressed (renal transplant recipient) patients can perform exten-
sive, exhaustive exercise, showing very restricted gene expression changes
(metabolism only), at the same time (135).
• Although gene expression profiling gives valuable information, the effects of
miRNAs need to be evaluated (58, 315).
• Proteomics and metabolomics have started to shed new light on the role of iso-
meric forms and post-translational modification of proteins.
• Metabolomics can identify individuals at risk for diabetes, effects of nutrition
and effects of exercise (38, 244, 331).
Controversies and future directions
The “omics” approach so far has had a major impact on knowledge about physio-
logical and pathological processes associated with exercise. An enormous amount
of new data has been generated, many pathways involved have been identified,
new isoforms detected, and multiple candidates for biomarkers found.
Considering the vast amount of data and the high complexity of analysis applied,
it is astonishing and potentially disappointing how little- if any- practical applica-
tion of “omics” technology exists. There is no doubt that “omics” is generating
huge steps in scientific advancement (for example detection of new proteins and
metabolites, including isoforms related to lipid metabolism, diabetes type-2, and
lipoprotein structure, as well as new biological pathways and gender/menstrual
phase dependent gene expression). Practical applications will arise from this, but
direct application of “omics” technologies for routine practical purposes (e.g.,
optimization of individual training/treatment programmes) will require one or
more further quantum leaps of technology and yet further increased complexity of
analysis. These advances need to be such that they re-simplify proceedings, and
analysis will have to integrate knowledge from different levels.
In terms of genome screening for talent and for susceptibility to injury, advances
may result from technological developments that will allow easier methods of
purification or whole genome sequencing. These technological advances will
facilitate access to instructive and sensitive personal data. It is unclear so far how
the enormous danger of misuse will be handled. Determination of single factors
like alpha actinin (ACTN3) variants – even if used commercially – is largely inef-
ficient. Interaction of many different genes in optimal composition is probably
required to make an athletic talent, and at this point, research is only starting. So
far, it seems highly unlikely that genomics alone will have the predictive power to
screen for gifted athletes (321).
At the level of gene expression, an enormous amount of knowledge about new
pathways and marker molecules involved in adaption to exercise has been gener-
ated – but as yet there is no assay to answer practical questions (concerning type,
intensity and duration of activity for adaptation to specific exercise) during train-
ing. Although the technology of gene expression profiling is quite advanced and
can be handled in many places, practical application of these technologies is not
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thinkable without rigorous standardization procedures and further technological
advances (e.g. isothermic amplification). The flow of up- and down-regulation of
genes in relation to exercise is so dependent on type, intensity, and duration of
exercise and nutritional and conditional factors including gender, that it is highly
doubtful if any experiment can ever be repeated by a different lab with identical
results – even when using the same platform. So, hotspots and time lines have to
be identified in order to make reliable predictions from such data, including inte-
gration of, and validation by regulatory mechanisms (miRNA) and post-transla-
tional modification, thus requiring proteomics and metabolomics.
The latter two technologies, as powerful as they already seem to be, are only just
now starting to explore the potential they really have. At present, exceptionally
well-equipped laboratories and highly specialized and experienced experts must
meet to enable meaningful proteomics and metabolomics studies. But as the
power and potential of this approach emerges, advancements of technologies can
be expected in the very near future. They will be combined with genomic and
gene expression data and resulting networks will then open new levels of meta-
analysis for interpretation. First steps are underway (108), although up to now, a
handy little tool for talent search or for individually optimized forms of training,
using “omics” type analysis, is not available.
Finally, the “omics” approach on all three classical levels will probably be helpful
in identifying misuse of substances or genetic interventions for doping purposes,
even though direct or specific detection procedures are often preferred in the fight
against doping (11). Work paving the way for “dopeomics” is underway (83,
337).
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